|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.70 EUR | -1.11% |
|
-1.53% | -9.06% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.44B | |||||
| 1,083B | |||||
| 626B | - | - | - | ||
| 442B | |||||
| 363B | |||||
| 295B |
Select your edition
All financial news and data tailored to specific country editions
